TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/11 16:34 | 5/6/11 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Leutzinger Kurt | NJ | O | CFO | S | -1,161 | 102.88 | 0 | -11 | -6 | 186 | D | |||||||||||||||
5/9/11 16:35 | 5/5/11 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Leutzinger Kurt | NJ | O | CFO | S | -980 | 102.61 | 0 | -10 | -5 | 198 | D | |||||||||||||||
3/14/08 09:35 | 3/12/08 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Leutzinger Kurt | NJ | O | EVP,CFO | P.m | 79 | 15.74 | 0 | 5 | 2 | 207 | D | |||||||||||||||
8/13/07 15:56 | 8/9/07 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Leutzinger Kurt | NJ | O | EVP,CFO | M.d | 62 | 3.00 | 0 | 21 | 11 | 202 | D | |||||||||||||||
11/25/03 15:22 | 11/24/03 | ABGX | Abgenix Inc | DE | Health | BioPrd | Biological Products, (No Diag | Leutzinger Kurt | CA | O | CFO | M.d | 154 | 3.37 | 0 | 46 | 28 | 212 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |